Delivery Order SPE2DB24D1205-SPE2DB25FCVCA

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,880.65 firm fixed-price contract is to provide Aranesp 200 MCG/0.4 ML syringes. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,142.44, is for the supply of Aranesp 60 MCG/0.3 ML syringes, a specialty medication used in the treatment of anemia. The contract has a period of performance through February 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a $6,065.17 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Aranesp 500 mcg/1 mL syringes to support federal healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,464.96 Firm Fixed Price contract is for the delivery of Aranesp 40 mcg/0.4 mL syringes, a specialty medication. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $5,529.80 contract is for the provision of Aranesp 500 mcg/1 mL syringes, a specialty pharmaceutical product. The delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,046.36, is for the supply of Aranesp 40 mcg/0.4 ml syringes, a specialty medication used for the treatment of anemia. The contract is a firm fixed-price arrangement with a completion date of February 20, 2025. This contract is part of a larger Indefinite...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,195.62 firm fixed-price contract is for the delivery of ARANESP 100 MCG/ML VIALML, a medication used to treat anemia. The contract has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract has a ceiling value of $1,313.92 and a performance period through March 11, 2024. It covers the delivery of Aranesp, a specialty pharmaceutical drug, in 40 mcg/0.4 mL syringes. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,635.33, is for the delivery of Aranesp 300 MCG/0.6 ML syringes to support federal healthcare programs. AmerisourceBergen is the prime contractor, and the contract has an ultimate completion date of January 8, 2025. The contract is a firm fixed-price delivery order, and it was not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,991.20 fixed-price contract provides ARANESP 200 MCG/0.4 ML SYRINGE 0.4ML, a medical supply product. This delivery order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCVCA
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,640.64, is for the delivery of Aranesp 100 MCG/0.5 ML syringes, a specialty medication used to treat anemia. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order does not have a set-aside designation, indicating open competition. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the efficient procurement of essential pharmaceutical and medical supplies.

Generated 6/21/25, 9:59 AM